George Magrath - 23 Dec 2024 Form 4 Insider Report for Opus Genetics, Inc. (IRD)

Role
Chief Executive Officer
Signature
/s/ Amy Rabourn, by Power of Attorney
Issuer symbol
IRD
Transactions as of
23 Dec 2024
Net transactions value
$0
Form type
4
Filing time
23 Dec 2024, 17:50:32 UTC
Previous filing
19 Nov 2024
Next filing
30 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRD Common Stock Award $0 +6,200 +1.3% $0.000000 499,150 23 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued to the Reporting Person to correct an inadvertent over-withholding of shares on November 1, 2024, in connection with the vesting of restricted stock units on that date.